These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23312388)
21. Determination of compound binding to plasma proteins. Dow N Curr Protoc Pharmacol; 2006 Oct; Chapter 7():Unit7.5. PubMed ID: 22294178 [TBL] [Abstract][Full Text] [Related]
22. Hydrophobic interactions responsible for unspecific binding of morphine-like drugs. Höllt V; Teschemacher H Naunyn Schmiedebergs Arch Pharmacol; 1975; 288(2-3):163-77. PubMed ID: 240130 [TBL] [Abstract][Full Text] [Related]
23. Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding. Curran RE; Claxton CR; Hutchison L; Harradine PJ; Martin IJ; Littlewood P Drug Metab Dispos; 2011 Mar; 39(3):551-7. PubMed ID: 21098647 [TBL] [Abstract][Full Text] [Related]
24. Development of a high throughput equilibrium dialysis method. Kariv I; Cao H; Oldenburg KR J Pharm Sci; 2001 May; 90(5):580-87. PubMed ID: 11288102 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis. Ha HR; Vozeh S; Follath F Ther Drug Monit; 1986; 8(3):331-5. PubMed ID: 3529516 [TBL] [Abstract][Full Text] [Related]
26. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay. Raghow G; Meyer MC; Straughn AB Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539 [TBL] [Abstract][Full Text] [Related]
27. Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and α-1 acid glycoprotein. Bista SR; Haywood A; Hardy J; Lobb M; Tapuni A; Norris R Xenobiotica; 2015 Mar; 45(3):207-12. PubMed ID: 25314012 [TBL] [Abstract][Full Text] [Related]
28. Solid-phase microextraction for assessment of plasma protein binding, a complement to rapid equilibrium dialysis. Ahmad S; Baker D; Murnane D; Spooner N; Gerhard U Bioanalysis; 2021 Jul; 13(14):1101-1111. PubMed ID: 34275331 [No Abstract] [Full Text] [Related]
29. Determination of protein binding of a highly lipophilic drug, isocarbacyclin methyl ester (TEI-9090), using a polydimethylsiloxane-coated glass beads assay. Minagawa T; Kohno Y; Suwa T; Tsuji A J Pharm Pharmacol; 1994 Oct; 46(10):838-43. PubMed ID: 7699573 [TBL] [Abstract][Full Text] [Related]
30. Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials. Reimerová P; Stariat J; Bavlovič Piskáčková H; Jansová H; Roh J; Kalinowski DS; Macháček M; Šimůnek T; Richardson DR; Štěrbová-Kovaříková P Anal Bioanal Chem; 2019 Apr; 411(11):2383-2394. PubMed ID: 30820631 [TBL] [Abstract][Full Text] [Related]
31. Protein binding of enprofylline. Tegnér K; Borgå O; Svensson I Eur J Clin Pharmacol; 1983; 25(5):703-8. PubMed ID: 6420163 [TBL] [Abstract][Full Text] [Related]
32. Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal. Berezhkovskiy LM J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):595-608. PubMed ID: 16841186 [TBL] [Abstract][Full Text] [Related]
33. The influence of volume ratio of ultrafiltrate of sample on the analysis of non-protein binding drugs in human plasma. Dong WC; Zhang JF; Hou ZL; Jiang XH; Zhang FC; Zhang HF; Jiang Y Analyst; 2013 Nov; 138(24):7369-75. PubMed ID: 24165752 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the erythrocyte partitioning method with two classical methods for estimating free drug fraction in plasma. Trung AH; Sirois G; Dubé LM; McGilveray IJ Biopharm Drug Dispos; 1984; 5(3):281-90. PubMed ID: 6487754 [TBL] [Abstract][Full Text] [Related]
35. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid. Barré J; Chamouard JM; Houin G; Tillement JP Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383 [TBL] [Abstract][Full Text] [Related]
36. Automation of plasma protein binding assay using rapid equilibrium dialysis device and Tecan workstation. Ye Z; Zetterberg C; Gao H J Pharm Biomed Anal; 2017 Jun; 140():210-214. PubMed ID: 28365514 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Commonly Used and New Methods to Determine Small Molecule Non-Specific Binding to Human Liver Microsomes. Wang T; Whitcher-Johnstone A; Scaringella YS; Keith-Luzzi M; Shao J; Taub ME; Chan TS J Pharm Sci; 2024 Jul; 113(7):1987-1995. PubMed ID: 38615815 [TBL] [Abstract][Full Text] [Related]
38. Propranolol binding in serum: comparison of methods and investigation of effects of drug concentration, pH, and temperature. Paxton JW; Calder RL J Pharmacol Methods; 1983 Aug; 10(1):1-11. PubMed ID: 6632919 [TBL] [Abstract][Full Text] [Related]
39. High-throughput determination of the free fraction of drugs strongly bound to plasma proteins. Schuhmacher J; Kohlsdorfer C; Bühner K; Brandenburger T; Kruk R J Pharm Sci; 2004 Apr; 93(4):816-30. PubMed ID: 14999720 [TBL] [Abstract][Full Text] [Related]
40. Plasma protein binding monitoring of therapeutic drugs in patients using single set of hollow fiber centrifugal ultrafiltration. Wang X; Li C; Du C; Gao JL; Zhao KX; Shi R; Jiang Y Bioanalysis; 2017 Apr; 9(7):579-592. PubMed ID: 28355126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]